ATE251896T1 - Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung - Google Patents

Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung

Info

Publication number
ATE251896T1
ATE251896T1 AT95940461T AT95940461T ATE251896T1 AT E251896 T1 ATE251896 T1 AT E251896T1 AT 95940461 T AT95940461 T AT 95940461T AT 95940461 T AT95940461 T AT 95940461T AT E251896 T1 ATE251896 T1 AT E251896T1
Authority
AT
Austria
Prior art keywords
production
sustained
granular preparations
continuous release
plasticizer
Prior art date
Application number
AT95940461T
Other languages
English (en)
Inventor
Hiroaki Nakagami
Kitakasai
Masazumi Kojima
Shinji Sagasaki
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE251896T1 publication Critical patent/ATE251896T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95940461T 1994-12-19 1995-12-18 Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung ATE251896T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31441494 1994-12-19
PCT/JP1995/002594 WO1996019200A1 (en) 1994-12-19 1995-12-18 Sustained-release granular preparation and process for producing the same

Publications (1)

Publication Number Publication Date
ATE251896T1 true ATE251896T1 (de) 2003-11-15

Family

ID=18053063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95940461T ATE251896T1 (de) 1994-12-19 1995-12-18 Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung

Country Status (14)

Country Link
US (2) US5858411A (de)
EP (1) EP0797987B1 (de)
JP (1) JP3893439B2 (de)
KR (1) KR100424931B1 (de)
CN (1) CN1093758C (de)
AT (1) ATE251896T1 (de)
DE (1) DE69531957T2 (de)
DK (1) DK0797987T3 (de)
ES (1) ES2210321T3 (de)
FI (1) FI119720B (de)
NO (1) NO320356B1 (de)
PT (1) PT797987E (de)
TW (1) TW406022B (de)
WO (1) WO1996019200A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) * 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
DK0901786T3 (da) 1997-08-11 2007-10-08 Pfizer Prod Inc Faste farmaceutiske dispersioner med foröget biotilgængelighed
US6632455B2 (en) * 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
JP4472184B2 (ja) * 1998-09-30 2010-06-02 ビーエーエスエフ ソシエタス・ヨーロピア 医薬投与剤形においてコーティング剤、結合剤および／またはフィルム形成助剤として使用される水溶性または水分散性のポリエーテル含有重合物の適用
ATE400251T1 (de) * 1999-02-09 2008-07-15 Pfizer Prod Inc Zusammensetzungen basischer arzneistoffe mit verbesserter bioverfügbarkeit
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
JP4310605B2 (ja) * 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US20050025825A1 (en) 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
JP5000504B2 (ja) * 2004-07-30 2012-08-15 フェリング ビー．ブイ． トラネキサム酸製剤
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
US20060275365A1 (en) * 2005-06-07 2006-12-07 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
WO2006133349A2 (en) * 2005-06-08 2006-12-14 Alpharma, Inc. Orally disintegrable sleep aid formulations
US7351740B2 (en) 2005-06-20 2008-04-01 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
PT2001445E (pt) * 2006-03-16 2014-10-24 Euro Celtique Sa Esferoides farmacêuticos
MX2008010233A (es) * 2008-03-10 2009-11-10 Eurodrug Lab B V Composicion de liberacion modificada, que comprende doxofilina.
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
WO2011091164A1 (en) * 2010-01-22 2011-07-28 Xenoport, Inc. Oral dosage forms having a high loading of a tranexamic acid prodrug
TW201132646A (en) * 2010-02-22 2011-10-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
GB201010083D0 (en) * 2010-06-16 2010-07-21 Univ Bradford Compositions and methods
KR102286952B1 (ko) * 2013-12-31 2021-08-09 롯데정밀화학 주식회사 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말
EP3340982B1 (de) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Verbindungen zur behandlung von immun- und entzündungserkrankungen
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
CN109414441A (zh) 2016-06-27 2019-03-01 艾其林医药公司 治疗医学障碍的喹唑啉和吲哚化合物
KR102632860B1 (ko) 2017-03-01 2024-02-02 아칠리온 파르마세우티칼스 인코포레이티드 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물
US20230022157A1 (en) 2018-08-20 2023-01-26 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
EP3846803A4 (de) 2018-09-06 2022-08-10 Achillion Pharmaceuticals, Inc. Makrocyclische verbindungen zur behandlung von medizinischen erkrankungen
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
CN119837855A (zh) 2019-12-19 2025-04-18 乔治亚州大学研究基金会 用于治疗细菌感染和增强抗生素的化合物
CN115362162A (zh) 2020-02-20 2022-11-18 艾其林医药公司 用于治疗补体因子d介导的障碍的杂芳基化合物
CA3193488A1 (en) 2020-09-23 2022-03-31 Jason Allan Wiles Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4329451A (en) * 1980-11-03 1982-05-11 The Dow Chemical Company Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
EP0421582A1 (de) * 1989-10-03 1991-04-10 Warner-Lambert Company Kaubare sprühgetrocknete spheroide Mikrokapseln, polymerüberzogene Mikrokapseln und Verfahren zu ihrer Herstellung
JPH03232814A (ja) * 1990-02-08 1991-10-16 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
JP2915590B2 (ja) * 1991-02-15 1999-07-05 第一製薬株式会社 マスクされた粒状物
AU1537292A (en) * 1991-04-16 1992-11-17 Nippon Shinyaku Co. Ltd. Method of manufacturing solid dispersion
DE4244466C2 (de) * 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten

Also Published As

Publication number Publication date
DK0797987T3 (da) 2004-02-16
EP0797987A4 (de) 1998-09-09
CN1093758C (zh) 2002-11-06
FI972622A0 (fi) 1997-06-18
JP3893439B2 (ja) 2007-03-14
CN1170357A (zh) 1998-01-14
NO972814L (no) 1997-08-18
WO1996019200A1 (en) 1996-06-27
DE69531957T2 (de) 2004-08-12
TW406022B (en) 2000-09-21
US5858411A (en) 1999-01-12
NO972814D0 (no) 1997-06-18
EP0797987A1 (de) 1997-10-01
PT797987E (pt) 2004-02-27
KR100424931B1 (ko) 2004-07-05
NO320356B1 (no) 2005-11-28
FI119720B (fi) 2009-02-27
EP0797987B1 (de) 2003-10-15
ES2210321T3 (es) 2004-07-01
US6030644A (en) 2000-02-29
FI972622L (fi) 1997-06-18
DE69531957D1 (de) 2003-11-20

Similar Documents

Publication Publication Date Title
DE69531957D1 (de) Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung
DE3854592D1 (de) Polyamidpulver aus Partikeln mit "Sandrose"-Struktur, Verfahren zur Herstellung des Polyamidpulvers.
DE68916048D1 (de) Verfahren zur Herstellung von monodispersen Polymerteilchen mit erhöhter Teilchengrösse.
LV10262B (en) Process for producing pharmaceutical compounds
DE69227974D1 (de) Mikrokapseln, welche anorganische Kolloiden enthalten, und Verfahren zur Herstellung
CA2098814A1 (en) Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances
DE69103472D1 (de) Monodisperses Kalziumkarbonat vom Vaterittyp, Verfahren zur Herstellung desselben und Verfahren zur Kontrolle des Teilchenwachstums und der Teilchenform.
DE69509671D1 (de) Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
DE69526787D1 (de) Biokompatibele und biodegradierbare Nanokapseln zur Absorption und Verabreichung von proteinischen Arzneimitteln
DE60020732D1 (de) Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
DE69623869D1 (de) Verfahren zur Herstellung von Ethylen-Vinylacetatcopolymeren, verseiften Produkten aus Vinylacetatpolymeren und Harzzusammensetzungen
DE59007616D1 (de) Verfahren zur Herstellung von kugelförmigen, harten mono- oder oligodispersen Teilchen aus Melaminharz.
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
UA26359C2 (uk) Спосіб виробhицтва граhул сечовиhи
EP1329211A4 (de) Antibakterielles harz
DE59010669D1 (de) Verfahren zur Herstellung eines agglomerierten Formpulvers aus Polytetrafluorethylen und hydrophoben Füllstoffen
EP0596138A4 (de) Feines schalenförmiges teilchen und seine herstellung.
DE69625813D1 (de) Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast
DE59008170D1 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel.
HUP9600099A2 (en) Process for producing flavano-lignane compositions of improved release and absorption, compositions produced this way find use of them for producing pharmaceutical compositions
DE59309706D1 (de) Verfahren zur Herstellung kugelförmiger Granulate aus pulverförmigen Feststoffen
MX9800964A (es) Manufactura de productos de polimeros.
CA2207334A1 (en) Sustained-release granular preparations and production process thereof
FR2689876B1 (fr) Dispersions silico-acryliques, leur procédé d'obtention, leur application en stéréophotolithographie et procédé de préparation d'objets en résine.
ATE102025T1 (de) Nichtfestes augenarzneimittel und verfahren zur herstellung dieses arzneimittels.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0797987

Country of ref document: EP

REN Ceased due to non-payment of the annual fee